Published February 2010 | Version v1
Journal article

Impact of F-18 fluorodeoxyglucose positron emission tomography - computed tomography on oncologic patient management: first 2 years' experience at a single Canadian cancer center

  • 1. Vancouver General Hospital, Division of Nuclear Medicine, Vancouver, British Columbia (Canada)
  • 2. British Columbia Cancer Agency, Vancouver, British Columbia (Canada)

Description

Purpose: The purpose of this study was to assess the influence of positron emission tomography-computed tomography (PET-CT) results on patient management from a single Canadian oncology center during its first 2 years of operation. Methods: A total of 3,779 consecutive patients, 18 years of age and older, who were referred for PET-CT imaging at the British Columbia Cancer Agency between July 1, 2005 and June 30, 2007, were included in this analysis. Results were tabulated from a standard questionnaire, which was given to referring physicians following completion of their patient's PET-CT study. Results: From July 1, 2005 to June 30, 2007, 3,779 consecutive fluoro-2-deoxyglucose PET-CT examinations were performed in patients aged 18 years or older. A total of 3,429 referring-physician surveys (90.7%) were returned. The results of the PET-CT study resulted in a change in treatment decision in 49.8% of the studies and resulted in improved decision making in 83.2% of the studies. Conclusion: This series demonstrated that the results from PET-CT studies performed at a single Canadian oncology center during the first 2 years of its operation altered patient management in 50% of cases and resulted in improved decision making in the majority of cases. (author)

Availability note (English)

Available from DOI: https://doi.org/10.1016/j.carj.2009.07.005

Additional details

Identifiers

Publishing Information

Journal Title
Canadian Association of Radiologists Journal
Journal Volume
61
Journal Issue
1
Journal Page Range
p. 13-18
ISSN
0846-5371

Optional Information

Notes
27 refs., 3 tabs., 3 figs.